Moderna and Institut Pasteur Sign Strategic Research Collaboration

Research partnership will advance the development of mRNA vaccines and passive immunity therapies for infectious diseases

05-Feb-2015 - United Kingdom

Moderna Therapeutics and the Institut Pasteur announced a long-term strategic research collaboration for the discovery and development of drugs and vaccines using Moderna's mRNA Therapeutics™ platform. Valera, a Moderna venture company, will manage the research collaboration for Moderna. Valera is focused exclusively on the advancement of vaccines and therapeutics for the prevention and treatment of viral, bacterial and parasitic infectious diseases.

Under the agreement, Valera will sponsor programs of preclinical and clinical research at the Institut Pasteur aimed at identifying and developing new approaches to combatting known and emerging viral and bacterial diseases.

Other news from the department science

More news from our other portals

All FT-IR spectrometer manufacturers at a glance